TAFAMIDIS for Atrial fibrillation: Side Effects & Safety Data
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
There are 51 adverse event reports in the FDA FAERS database where TAFAMIDIS was used for Atrial fibrillation.
Most Reported Side Effects for TAFAMIDIS
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 2,553 | 27.7% | 2,510 | 213 |
| Dyspnoea | 608 | 6.6% | 98 | 248 |
| Off label use | 571 | 6.2% | 218 | 157 |
| Cardiac failure | 444 | 4.8% | 196 | 205 |
| Fatigue | 438 | 4.8% | 45 | 114 |
| Fall | 372 | 4.0% | 87 | 240 |
| Malaise | 301 | 3.3% | 38 | 85 |
| Hypoacusis | 298 | 3.2% | 30 | 44 |
| Atrial fibrillation | 296 | 3.2% | 41 | 107 |
| Asthenia | 256 | 2.8% | 45 | 125 |
| Dizziness | 255 | 2.8% | 16 | 75 |
| Weight decreased | 253 | 2.8% | 67 | 119 |
| Cardiac failure congestive | 241 | 2.6% | 114 | 125 |
| Cardiac disorder | 234 | 2.5% | 62 | 114 |
| Cerebrovascular accident | 219 | 2.4% | 35 | 114 |
Other Indications for TAFAMIDIS
Cardiac amyloidosis (2,450)
Amyloidosis (2,264)
Acquired attr amyloidosis (662)
Cardiac disorder (255)
Amyloidosis senile (222)
Product used for unknown indication (177)
Cardiomyopathy (163)
Cardiac failure (117)
Cardiac failure congestive (112)
Familial amyloidosis (64)
Other Drugs Used for Atrial fibrillation
RIVAROXABAN (52,584)
DABIGATRAN ETEXILATE (20,492)
APIXABAN (10,500)
AMIODARONE (9,083)
WARFARIN (8,680)
EDOXABAN (3,855)
ASPIRIN (2,993)
DOFETILIDE (2,439)
PRADAXA (2,325)
METOPROLOL (1,542)